Tarabichi M
Section of Otolaryngology, American Hospital-Dubai, United Arab Emirates.
Am J Otol. 1997 Sep;18(5):544-9.
This study aimed to describe and evaluate endoscopic technique for treatment of acquired cholesteatoma.
This study was a case series.
The study was performed in a private otolaryngology practice.
Thirty-eight adult patients with acquired cholesteatoma and no previous ear surgery composed the patient population.
Thirty-six patients underwent transcanal endoscopic tympanotomy and extended atticotomy with removal of the cholesteatoma sac; the attic defect was reconstructed in 25 patients and was packed open in 11 patients. Two patients underwent traditional postauricular procedures.
The main outcome measure was disease-free ears as evident on: 1) clinical examination at 1 year follow-up for 30 patients and at 2 years for 13 patients; and 2) surgical exploration in 6 patients at 2 years.
There were no significant complications associated with the 36 endoscopic procedures: 29 of 30 patients were disease free at 1 year, 10 of 13 were disease free on clinical examination at 2 years, and 4 of 6 were disease free on surgical exploration at 2 years.
Early results indicate that endoscopic removal of cholesteatoma offers a safe and effective transcanal alternative to postauricular procedures.
本研究旨在描述和评估治疗获得性胆脂瘤的内镜技术。
本研究为病例系列研究。
本研究在一家私立耳鼻喉科诊所进行。
38例患有获得性胆脂瘤且既往无耳部手术史的成年患者构成了研究人群。
36例患者接受经耳道内镜鼓室切开术及扩大上鼓室切开术并切除胆脂瘤囊;25例患者重建上鼓室缺损,11例患者开放填塞。2例患者接受传统耳后手术。
主要观察指标为无疾病耳,具体表现为:1)30例患者在1年随访时及13例患者在2年随访时进行临床检查;2)6例患者在2年时进行手术探查。
36例内镜手术均未出现明显并发症:30例患者中有29例在1年时无疾病,13例患者中有10例在2年临床检查时无疾病,6例患者中有4例在2年手术探查时无疾病。
早期结果表明,内镜下切除胆脂瘤为耳后手术提供了一种安全有效的经耳道替代方法。